Login

Christoph Vilanek of Freenet AG speaks at the 25 Years MCI event, while Thierry Bernard, CEO of QIAGEN N.V., participates in the Distinguished Guest Livetalk. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek, CEO of Freenet

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Metals Australia Advances Lac Rainy Graphite Project
00:10:00
Kelly Partners: Transforming Accounting with a Modern Approach and Significant Growth Potential
00:10:00
Catalyst Metals Targets 200K Oz Annual Gold Production with Strategic Acquisitions
00:10:00
A Vision for the Future: Piers Bolger - Head of Infinity Asset Management
00:10:00
Addressing Geopolitical and Economic Influences on Wealth Management Strategies | Andrew Schlossberg , CEO , Invesco.
00:10:00
Oil Market Dynamics: Supply and Demand Insights
00:00:00
The practice of medicine is more than just prescribing medicines / Cameron Nutt, Medical Student, HMS
00:10:00
Navigating Multi-Strategy Asset Allocation: Insights from Industry Leaders at SALT 2019 | Keith Haydon, Troy Gayeski, Joshua S. Friedman, John Graham
00:10:00
BMEX Gold: Quebec Gold Projects Exploration Update
00:10:00
Focused on investing in gender diverse founding teams and raising the equity|Avantika Daing,Managing Partner,Plum Alley Investments
00:10:00
Outcrop Silver's High-Grade Maiden Resource Estimate and Santa Ana Project Overview
00:10:00
Institutions who provide the FUEL for our FOCUS on helping disruptive founders|Maggie Vo,Managing General Partner and Chief Investment Officer,Fuel Venture Capital

© 2017 - Neuhu+